Clinical Research Centre (Singapore)

Clinical Research Centre (Singapore)
Name	Clinical Research Centre (Singapore)
Established	1979
Location	Singapore
Type	Research institute
Parent	Ministry of Health (Singapore)

Clinical Research Centre (Singapore) is a biomedical research institute located in Singapore that supports clinical studies, translational medicine, and investigator-initiated trials. The centre operates within a national health infrastructure alongside institutions such as Singapore General Hospital, National University Hospital (Singapore), Tan Tock Seng Hospital, KK Women's and Children's Hospital, and Changi General Hospital, and interfaces with agencies including Ministry of Health (Singapore), Health Sciences Authority (Singapore), Agency for Science, Technology and Research, and National Medical Research Council. It provides operational, regulatory, and specialist support for investigators from universities, polytechnics, and healthcare institutions such as National University of Singapore, Nanyang Technological University, Duke-NUS Medical School, and Yong Loo Lin School of Medicine.

History

The centre was established in 1979 during a period of healthcare expansion that also saw growth at Singapore General Hospital and the development of tertiary care at Tan Tock Seng Hospital. Early milestones paralleled initiatives by Ministry of Health (Singapore), regulatory reforms by the Health Sciences Authority (Singapore), and the formation of research councils including the National Medical Research Council. Over decades the centre expanded alongside academic partners such as the National University of Singapore and Duke-NUS Medical School, and infrastructural projects including those at Singapore Institute of Technology and Research, Innovation and Enterprise (RIE) 2015. Major phases included upgrades coincident with national strategies like Biomedical Sciences Initiative and collaborations with multinational partners such as GlaxoSmithKline, Pfizer, Roche, and AstraZeneca.

Organisation and Governance

Governance frameworks reflect alignment with Ministry of Health (Singapore) policy and oversight from the Institutional Review Board (IRB) network and the National Medical Research Council. The organisational structure includes divisions for clinical operations, biostatistics, data management, and regulatory affairs that liaise with institutions like Singapore Health Services, National Healthcare Group, and Health Promotion Board. Leadership has engaged with global entities such as the World Health Organization, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and ClinicalTrials.gov standards, and collaborates with accreditation bodies including Joint Commission International and ISO. Administrative and ethical governance draws from precedents set by centres at Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and regulatory models from European Medicines Agency.

Facilities and Capabilities

Facilities include inpatient wards, outpatient clinics, Phase I units, biobanking infrastructure, and Good Clinical Practice-compliant units comparable to facilities at Singapore General Hospital and National University Hospital (Singapore). Laboratory capabilities support genomics, proteomics, and metabolomics with equipment and cores similar to those at Genome Institute of Singapore and Nanyang Technological University Lee Kong Chian School of Medicine research cores. Imaging capabilities interface with departments modeled on KK Women's and Children's Hospital radiology and include MRI, CT, PET, and ultrasound suites. The centre maintains electronic data capture and clinical data warehouses compatible with standards used by Electronic Health Record (EHR) programmes in institutions such as HealthHub (Singapore).

Research Programs and Specialties

Research programs span cardiology, oncology, infectious diseases, endocrinology, neurology, and gerontology, reflecting clinical ties to specialty centers like National Heart Centre Singapore, National Cancer Centre Singapore, and Tan Tock Seng Hospital infectious disease units. The centre supports translational projects in precision medicine, pharmacogenomics, vaccine development, and health services research with collaborations involving Duke-NUS Medical School, National Neuroscience Institute, Singapore Immunology Network, and international centers such as Karolinska Institute, Imperial College London, and Harvard Medical School. Specialty research includes trials in diabetes with links to Singapore Diabetes Society, oncology protocols coordinated with National Cancer Centre Singapore, and respiratory disease studies in partnership with Singapore General Hospital pulmonary teams.

Clinical Trials and Participant Services

The centre manages investigator-initiated and industry-sponsored trials across phases I–IV, partnering with sponsors such as Novartis, Johnson & Johnson, AbbVie, and Bristol-Myers Squibb. Participant services include informed consent coordination, outpatient monitoring, adverse event reporting, and pharmacovigilance aligned with Health Sciences Authority (Singapore). Recruitment pipelines draw from patient populations at Khoo Teck Puat Hospital, Sengkang General Hospital, and community clinics associated with SingHealth Polyclinics and National Healthcare Group Polyclinics. Data management and biostatistics units employ methodologies consistent with guidelines from CONSORT, STROBE, and ICH-GCP.

Collaborations and Partnerships

Strategic partnerships extend to academic, industry, and governmental collaborators including National University of Singapore, Duke-NUS Medical School, Agency for Science, Technology and Research, multinational pharmaceutical companies, and non-profits such as Bill & Melinda Gates Foundation. International research links include networks with World Health Organization, Wellcome Trust, European Union Horizon 2020, and regional bodies like Asia-Pacific Economic Cooperation (APEC). Collaborative projects have involved public health responses coordinated with Ministry of Health (Singapore) and emergency preparedness exercises analogous to collaborations among Centers for Disease Control and Prevention and Public Health England.

Impact and Contributions to Healthcare Practice

The centre has contributed to clinical guideline development, investigator training, and improved trial conduct across Singapore’s healthcare ecosystem, influencing practice at Singapore General Hospital, National University Hospital (Singapore), and specialist centres including National Heart Centre Singapore and National Cancer Centre Singapore. Outputs include publications informing policy at institutions like the National Medical Research Council and implementation science projects aligned with World Health Organization recommendations. The centre’s role in capacity-building has strengthened clinical research competencies across universities and hospitals and supported translational advances adopted by practitioners in tertiary centres, community hospitals such as KTPH and regional health networks.

Category:Research institutes in Singapore